Despite having lived with five different cancers over the last two decades—prostate, thyroid, kidney, appendix, and skin—Joel Nowak doesn't consider himself a "survivor." Rather, as a self-described "cancer thriver," ...
Aug 22, 2022
0
7
Researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are.
Aug 12, 2022
0
87
My oncologist has one of those little motivational prints hanging on his waiting room wall, with the simple statement: "trust your instincts." One day, bored with the long purgatory of the waiting room, I tweet this news ...
Aug 4, 2022
0
16
Researchers at the Vancouver Prostate Center have developed a new blood test that provides unprecedented insight into a patient's cancer make-up, potentially allowing doctors to better select treatment options that will improve ...
Jul 20, 2022
0
1924
A diagnosis of prostate cancer can bring up many worries. There may be a general fear around having cancer, questions about the best treatment, and anxiety about how a treatment could affect such vital things as sexual function ...
Jul 7, 2022
0
23
Researchers who treated a group of post-surgery bladder cancer patients with the immunotherapy drug atezolizumab have found that patients whose blood contained circulating tumor DNA (ctDNA), responded very well to the treatment.
Jul 4, 2022
0
7
For patients with low- or intermediate-risk localized prostate cancer, enzalutamide monotherapy plus active surveillance (AS) is well tolerated and induces a significant treatment response compared with AS alone, according ...
Jun 27, 2022
0
1
Researchers have recommended changes to how cancer patients are treated, after a new UCL-led study discovered that chemotherapy is significantly more effective for some men with advanced prostate cancer than others.
Jun 24, 2022
0
8
In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be "intermediate risk"—mostly, small tumors confined to one area of the prostate. At ...
Jun 15, 2022
0
89
As the cost of genome and exome sequencing falls, its use in characterizing rare diseases and personalizing cancer treatment, for example, is becoming far more frequent. But such analyses may throw up findings unrelated to ...
Jun 10, 2022
0
17
